TY - JOUR TI - Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis AU - Shams, Anwar AU - Binothman, Najat AU - Boudreault, Julien AU - Wang, Ni AU - Shams, Fuad AU - Hamam, Dana AU - Tian, Jun AU - Moamer, Alaa AU - Dai, Meiou AU - Lebrun, Jean-Jacques AU - Ali, Suhad T2 - Oncogenesis AB - Dedifferentiation increased cellular plasticity and stemness are established derivers of tumor heterogeneity, metastasis and therapeutic failure resulting in incurable cancers. Therefore, it is essential to decipher pro/forward-differentiation mechanisms in cancer that may serve as therapeutic targets. We found that interfering with expression of the receptor for the lactogenic hormone prolactin (PRLR) in breast cancer cells representative of the luminal and epithelial breast cancer subtypes (hormone receptor positive (HR+) and HER2-enriched (HER2-E) resulted in loss of their differentiation state, enriched for stem-like cell subpopulations, and increased their tumorigenic capacity in a subtype-specific manner. Loss of PRLR expression in HR+ breast cancer cells caused their dedifferentiation generating a mesenchymal-basal-like phenotype enriched in CD44+ breast cancer stem-like cells (BCSCs) showing high tumorigenic and metastatic capacities and resistance to anti-hormonal therapy. Whereas loss of PRLR expression in HER2-E breast cancer cells resulted in loss of their luminal differentiation yet enriched for epithelial ALDH+ BCSC population showing elevated HER2-driven tumorigenic, multi-organ metastatic spread, and resistance to anti-HER2 therapy. Collectively, this study defines PRLR as a driver of precise luminal and epithelial differentiation limiting cellular plasticity, stemness, and tumorigenesis and emphasizing the function of pro/forward-differentiation pathways as a foundation for the discovery of anti-cancer therapeutic targets. DA - 2021/01/14/ PY - 2021 DO - 10.1038/s41389-020-00297-5 DP - www.nature.com VL - 10 IS - 1 SP - 1 EP - 16 LA - en SN - 2157-9024 UR - https://www.nature.com/articles/s41389-020-00297-5 Y2 - 2021/01/14/17:47:31 ER -